Homology Medicines Inc
XBER:35H
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Homology Medicines Inc
XBER:35H
|
US |
|
C
|
Cellectis SA
SWB:ZVA
|
FR |
|
H
|
Haseko Corp
F:HS6
|
JP |
|
Daiwabo Holdings Co Ltd
TSE:3107
|
JP |
|
A
|
Atlantia SpA
XBER:AU9
|
IT |
|
Murphy Oil Corp
NYSE:MUR
|
US |
|
China Minsheng Banking Corp Ltd
SSE:600016
|
CN |
|
M
|
Magna International Inc
BMV:MGAN
|
CA |
|
S
|
Schibsted ASA
SWB:XPG
|
NO |
|
Dunelm Group PLC
LSE:DNLM
|
UK |
|
Horizon Construction Development Ltd
OTC:HRZCF
|
CN |
|
T
|
TriMas Corp
NASDAQ:TRS
|
US |
|
K
|
KB Home
XMUN:KBH
|
US |
|
T
|
Tyson Foods Inc
XBER:TF7A
|
US |
|
Magazine Luiza SA
BOVESPA:MGLU3
|
BR |
|
Nomad Foods Ltd
NYSE:NOMD
|
UK |
|
A
|
Ad Pepper Media International NV
SWB:APM
|
DE |
|
LG Display Co Ltd
KRX:034220
|
KR |
|
S
|
Schroder European Real Estate Investment Trust PLC
JSE:SCD
|
UK |
|
C
|
Carlsberg A/S
LSE:0AI3
|
DK |
Bankruptcy Probability
Homology Medicines Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Homology Medicines Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Homology Medicines Inc
NASDAQ:QTTB
|
260.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
454.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
200.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Homology Medicines Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Homology Medicines Inc has total debt of 3.5m USD. This includes both short-term (0 USD) and long-term (3.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
